Latest news with #Jean-LucProcaccini
Yahoo
2 days ago
- Business
- Yahoo
GE HealthCare and MIM Software release integrated imaging platform
GE HealthCare has released software combining its own imaging functionalities with tools enabled by a platform developed by MIM Software, to enhance imaging workflows in indications including oncology and cardiology. The integration marks the imaging giant's first combined release with Mim Software's Mim Encore platform since it acquired the company in 2024 for around $290m. Mim Encore is designed to provide features including structured reporting and interpretation tools for PET/CT, SPECT/CT, and multi-modality fusion imaging within a single platform. The platform primarily adds resolution recovery and image-enhancing tools that are tailored for GE HealthCare scanners, Ohio-based Mim Software said. For oncology, the platform in combination with GE HealthCare's systems means that SPECT image processing and analysis can be simplified by the software's ability to perform resolution recovery, attenuation and scatter correction, advanced filtering, and motion correction. Similar functionality through the combination is now possible across cardiology, with Mim's platform also enabling 3D rendering and advanced corrections for GE HealthCare's neurological imaging scanners. Jean-Luc Procaccini, president and CEO for molecular imaging and computed tomography at GE HealthCare commented: 'We are committed to delivering technology that unifies data across systems and organisations, breaking down workflow barriers to help drive better clinical outcomes and elevate the standard of patient care.' According to GE HealthCare, the integration with Mim's platform will allow clinicians and researchers to deliver 'fast, accurate diagnoses, and onboard users quickly' and to realise efficiencies and consistencies in work and communication between clinicians. 'Customers are telling us that this pairing is exactly what users have been looking for. The combined solution enables streamlined, accurate reading of images, supports quantitative analysis out of the box, and helps eliminate manual entries,' said Andrew Nelson, CEO of Mim Software. 'As we continue to evolve our vertically integrated products based on user input, we remain focused on creating a user-friendly, vendor-neutral, future-ready experience designed to scale with advanced molecular imaging needs,' Nelson added. This week at NVIDIA's GTC conference, taking place in Paris, France from 10-12 June, the company announced a new partnership with GE HealthCare that will focus on developing autonomous X-ray technologies and ultrasound applications. "GE HealthCare and MIM Software release integrated imaging platform" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Business Wire
2 days ago
- Business
- Business Wire
GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) proudly announces the combination of GE HealthCare's proprietary features and algorithms with MIM Encore, marking a significant milestone in its mission to deliver precision care through advanced digital solutions. This implementation brings powerful new features to healthcare organizations boasting GE HealthCare systems alongside MIM software with MIM Encore, a cutting-edge, single platform design based on user input to help enhance diagnostic confidence, streamline workflows, and support the future of personalized medicine. 'In today's rapidly evolving healthcare landscape, operational efficiency and seamless collaboration are not just goals — they're the cornerstone to success. That's why we aim to provide tools that can help enhance providers' confidence in decision making and support patients in receiving personalized care,' shares Jean-Luc Procaccini, President & CEO, Molecular Imaging & Computed Tomography, GE HealthCare. 'We are committed to delivering technology that unifies data across systems and organizations, breaking down workflow barriers to help drive better clinical outcomes and elevate the standard of patient care.' New capabilities now available to GE HealthCare, MIM Software customers Now featuring dedicated post-processing tools for GE HealthCare systems, MIM Encore helps deliver excellent image quality with minimal effort, streamlining everyday nuclear medicine and cardiology workflows. Users can expect high image quality with minimal effort, along with automated read preparation, structured reporting, and flexible interpretation tools for PET/CT, SPECT/CT, and multi-modality fusion — all in a single platform. MIM Encore empowers clinicians and researchers to help deliver fast, accurate diagnoses, and onboard users quickly, for efficiencies and consistencies in work and communication between clinicians. 'Customers are telling us that this pairing is exactly what users have been looking for. The combined solution enables streamlined, accurate reading of images, supports quantitative analysis out of the box, and helps eliminate manual entries,' says Andrew Nelson, CEO, MIM Software, a GE HealthCare Company. 'As we continue to evolve our vertically integrated products based on user input, we remain focused on creating a user-friendly, vendor-neutral, future ready experience designed to scale with advanced molecular imaging needs.' With easy adoption across departments and roles — as well as few manual steps — MIM Encore adds resolution recovery and image-enhancing tools tailored for GE HealthCare scanners, streamlining workflows while helping elevate diagnostic confidence across care areas. Oncology: MIM Software's tools, now paired with GE HealthCare systems, simplify SPECT image processing with reconstruction and configurable enhancements, including resolution recovery, attenuation and scatter correction, advanced filtering, and motion correction. As a result, clinicians can view dynamic and static scans, share images easily, and access advanced quantitation tools — helping deliver clear insights with less manual effort. Cardiology: GE HealthCare's cardiac imaging is now even stronger with MIM technology's advanced PET and SPECT tools, enabling fast, high-quality reconstructions and quantitative analysis. Features like motion correction, automated quality checks, and intuitive displays help deliver accurate and efficient cardiac care. With support for key radiotracers and advanced algorithms like Evolution for Cardiac — developed at Johns Hopkins and University of North Carolina — MIM Encore is designed to deliver high-quality images at reduced acquisition times or doses i. Neurology: As a leader in neurodegenerative imaging, GE HealthCare with MIM technology now offers reconstruction workflows with 3D rendering and advanced corrections. As a result, clinicians benefit from consistent, high-quality images and easy-to-use tools for confident diagnosis, and assistance in treatment planning and evaluation. Also new, GE HealthCare's Effortless Workflow seamlessly integrates with MIM Encore, enabling clinicians to manage rising caseloads with intuitive interfaces, customizable displays, and automation that can help bridge experience gaps and reduces burnout. GE HealthCare acquired MIM Software in 2024, bringing together two industry leaders with expertise in multi-modality imaging, quantitation, workflow automation and molecular imaging. For more information on GE HealthCare's molecular imaging portfolio – including MIM Encore – please visit and SNMMI show attendees are also encouraged stop by the company's booth (#638 and #1023) at New Orleans Ernest N. Morial Convention Center in New Orleans, Louisiana from June 21-24. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™.
Yahoo
28-03-2025
- Business
- Yahoo
GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions
GE HealthCare's Revolution Vibe CTi enables more facilities to elevate patient care by offering advanced cardiac imaging technology that helps deliver fast, accurate diagnoses, improve operational efficiency, and enhance patient outcomes. Cardiovascular disease (CVD) is the leading cause of death and healthcare costs worldwide,ii with research projecting it could cause over 23 million deaths by The average number of cardiac computed tomography (CT) procedures performed per site is expected to increase 175 percent,iv highlighting its value as a first-line imaging tool for diagnosis, treatment planning, and post-treatment follow-up. CHICAGO, March 28, 2025--(BUSINESS WIRE)--At the American College of Cardiology 2025 meeting, GE HealthCare (Nasdaq: GEHC) will proudly introduce Revolution™ Vibe,i a new computed tomography (CT) system with Unlimited One-Beat Cardiac imaging to deliver consistent, high-quality images for patients, even in challenging cases like atrial fibrillation and heavily calcified coronaries. Combined with the company's impressive ECG-less Cardiac, TrueFidelity DL, SnapShot Freeze 2, and Effortless Workflow's AI-powered solutions, Revolution Vibe enables fast, accurate diagnoses, a more comfortable patient experience, and more efficient workflows.v As cardiovascular disease (CVD) continues to rise globally,vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians. The National Institute for Health and Care Excellence (NICE) recommends CCTA as the first-line investigation for patients with chest pain due to suspected CAD, highlighting its importance in improving diagnostic certainty. vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. "Expanding access to CCTA is crucial for managing the rising prevalence of CVD, ensuring timely and accurate diagnoses for a larger patient population," shares Jean-Luc Procaccini, President and CEO, Molecular Imaging and Computed Tomography, GE HealthCare. "Our introduction of Revolution Vibe underscores our commitment to this mission. The system is designed to encourage the broader adoption of and access to cardiac imaging, combining advanced technology with AI-powered solutions to deliver fast, accurate diagnoses and a more comfortable patient experience. It is designed to empower healthcare providers to offer the highest quality care, even in the most challenging cases." For CCTA to be truly effective, the CT system must be designed to address the most difficult cardiac exams, including irregularities in heart rhythms, patients with limited cooperation, and those with calcification, stents or bypasses. These complications challenge cardiologists and radiologists alike, often leading to repeat scans, inaccurate diagnoses, heightened patient risk and dissatisfaction, and increased ix, x, xi, xii, xiii, xiv, xv GE HealthCare designed Revolution Vibe to address these challenges. The 'all in one' system provides advanced cardiac CT solutions to help make CCTA more accessible to more facilities and patients, while also enabling greater diagnostic confidence, patient comfort, and workflow efficiency. "Revolution Vibe has significantly enhanced our cardiac imaging capabilities, doubling our CCTA capacity while reducing scan times and improving image quality," shares Dr. Christopher Ahlers, Radiologist and Managing Partner at Radiomed. "The advanced technology streamlines workflows, reduces reliance on invasive diagnostics, and ensures high-quality care for all patients, including those with challenging conditions. By adopting Revolution Vibe, we have improved operational efficiency, increased diagnostic confidence, and elevated patient satisfaction, positioning us at the forefront of cardiac care." Revolution Vibe enhances cardiac capabilities, enabling Unlimited One-Beat Cardiac imaging. This advanced technology offers clear, full-heart images at low dose, improving access for patients with complex conditions like atrial fibrillation, breath-holding difficulties, heavily calcified coronaries, in-stent restenosis, and cases without an ECG trace. TrueFidelity DL images for cardiac and SnapShot Freeze 2 offer Revolution Vibe users impressive image quality with motion free images. The system also offers ECG-less Cardiac to help improve patient access and simplify preparation for exams without an ECG connection, making it ideal for situations where speed is a priority or when the ECG signal is unavailable. Effortless Cardiac Workflow also optimizes the system for cardiac scans, leveraging AI to automatically select protocols and position the patient – optimizing scanning time and making it easy to use for every user, even junior or inexperienced technologists. In a clinical evaluation, the one-step decision tree workflow helped reduce exam time by 50 percent, freeing up four minutes of radiologists' time per It also helped reduce the patient preparation process by up to five minutes per Much of this time is saved due to reduced positioning time, minimized usage of beta blockers, and eliminating the need for an ECG connection when the cardiac exam needs to be prioritized for patient access and speed. Finally, Revolution Vibe is designed to help healthcare facilities expand their service lines and manage lifecycle costs effectively, driving topline growth. With the growing need for cardiac CT, the system's versatility and ability to handle increased cardiac exams and general imaging needs make it accessible to more facilities. Beyond initial costs, Revolution Vibe offers energy-efficient design, extensive training, fleet management, and Smart Subscription, ensuring facilities stay updated with the latest technology. This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. For more information on Revolution Vibe, please visit Those attending the American College of Cardiology (ACC) 2025 meeting in Chicago are also invited to experience the system's formal unveiling in GE HealthCare's booth (#9013) on Saturday, March 29 at 10:30 a.m. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™. Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website for more information. i Revolution Vibe is CE marked and 510(k) pending with the U.S. FDA. Not available for sale in the United States or all regions. ii Shapiro MD et al. Eur J Radiol. 2008;66(1):37–41. doi:10.1016/ iii Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. (2012) 380:2095–128. 10.1016/S0140-6736(12)61728-0. iv IMV. 2023 CT Market Outlook Report (p. 45). v Walter, M. (2024, November 8). "a huge win": CMS significantly increases Medicare payments for cardiac CT. Cardiovascular Business. vi World Health Organization. Cardiovascular diseases (CVDs). June 11, 2021. Available at: Accessed February 2023 vii Moss AJ et al. The Updated NICE Guidelines: Cardiac CT as the First-Line Test for Coronary Artery Disease. Curr Cardiovasc Imaging Rep (2017) 10: 15. viii Shapiro MD et al. EurJ Radiol. 2008;66(1):37–41. ix Pannu HK et al. J Comput Assist Tomogr. 2008 Mar-Apr;32(2):247-51. x Graaf D et al. American Journal of Cardiology. 2010;105(6):767–772. xi Techasith T et al. J Cardiovasc Comput Tomogr. 2011;5(4):255–263. xii Ghoshhajra BB et al. Am J Med. 2012;125(8):764–772. xiii Hamid S et al. Am J Emerg Med. 2010;28(4):494–498. xiv Cotarlan V et al. Am J Cardiol. 2013;111(5):661–666. xv Hoffmann U et al. Am Heart J. 2012;163(3):330-338. xvi GE HealthCare case study. "Revolution Vibe: A new vision for heart at Radiomed." View source version on Contacts GE HealthCare Media Contact: Margaret SteinhafelM +1 608 381 Sign in to access your portfolio
